• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Is leukopenia and lymphopenia a characteristic feature of COVID-19 in children?

Emily

Editor, Senior Moderator
(Note that a very different result was found in children in Italy https://flutrackers.com/forum/forum...of-children-infected-with-sars-cov-2-in-italy)

http://www.pjms.org.pk/index.php/pjms/article/view/3848

Bari, A., CH, A., Bano, I., & Saqlain, N. (2021). Is leukopenia and lymphopenia a characteristic feature of COVID-19 in children?. Pakistan Journal of Medical Sciences, 37(3). https://doi.org/10.12669/pjms.37.3.3848

Keywords: coronavirus disease 2019, children, acute respiratory disease, mortality, prognosis, blood picture

Abstract

Objectives: To analyze whether leucopenia and lymphopenia a characteristic feature of children with COVID-19 and to find out its association with the disease severity.
Methods: This was a descriptive cross-sectional study conducted at The Children?s Hospital Lahore from March 2020 to October 2020. All confirmed cases of COVID-19 infection and post-COVID MIS-C/Kawasaki Disease diagnosed on the basis of RT-PCR and Antibody test respectively were included. Complete blood and differential counts were performed on the day of admission.
Results: Out of a total of 83 patients 60 (72%) were diagnosed as COVID-19 and 23 (28%) as post-COVID MIS-C/KD. The mean age of children was 7.0?4.3 years (95%CI: 6.07 - 8.75) with a male preponderance 51 (61%). Twenty (24%) children had an underlying comorbidity and 7 (8%) were surgical cases. Our case fatality rate was 5 (6%) and all children who died had an underlying comorbid condition. In both, COVID and MIS-C/KD the mean leukocyte count was (14.0 ? 12.5 vs 13.6 ? 6.9 x109/L), respectively (p=0.888). The mean lymphocyte count in children with COVID was (39.1 ? 21.4%). Patients with MIS-C/KD showed significantly higher levels of neutrophil count (76.5 ? 15.0%) as compared to children with COVID (52.0 ? 22.1%), absolute lymphocyte count was (5.02?4.81 vs 2.13?0.95 x109/L) in COVID and MIS-C respectively (p=<0.001). In 60 COVID-19 patients, the mean neutrophil lymphocyte ratio (NLR) in mild-moderate and severe-critical group was 2.00 and 5.08 respectively (p=0.009).
Conclusion: The blood picture of COVID-19 in children does not show leukopenia. NLR was a prognostic factor to assess the severity in COVID-19 patients. The presence of an underlying comorbid conditions is significant a risk factor for poor outcome.
doi: https://doi.org/10.12669/pjms.37.3.3848
 
Back
Top Bottom